WTX-613, (JZP898) a selectively activated IFN INDUKINE? molecule, reprograms the tumor microenvironment and generates robust anti-tumor immunity as a monotherapy and in combination with checkpoint inhibitors

Christopher J. Nirschl,Heather R. Brodkin, Celesztina Domonkos,Kyriakos Economides,Daniel J. Hicklin, Nesreen Ismail, Cynthia Seidel-Dugan, Philipp Steiner, Zoe Steuert, William M. Winston, Andres Salmeron

CANCER RESEARCH(2023)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要